Literature DB >> 22548564

Cardiovascular defense challenges at the basic, clinical, and population levels.

Jason C Kovacic1,2, Jose M Castellano1,2, Valentin Fuster1,2,3.   

Abstract

Cardiovascular disease (CVD) is now the leading cause of mortality worldwide. Particularly in low and middle income countries, rapid urbanization and secondary factors, such as increasing obesity, poor diet, and lack of exercise, have combined to propel CVD into this position. Given the enormous scope of this problem and the complex cultural, societal, and political issues that are involved, an equally sophisticated and multipronged approach is required to combat CVD at the global level. In this review, we outline the basic, clinical, and population level challenges that we face in defending ourselves against this disease.
© 2012 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22548564      PMCID: PMC3752384          DOI: 10.1111/j.1749-6632.2012.06495.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   6.499


  23 in total

1.  Cardiovascular risk reduction via increasing HDL cholesterol: the promise of the dal-OUTCOMES Trial.

Authors:  Kyaw Soe; Anis Alam; Charles Philip; Edison Ruiz; Keshwar Ramkissoon; Samy I McFarlane
Journal:  Curr Diab Rep       Date:  2011-02       Impact factor: 4.810

Review 2.  Promoting mechanisms of vascular health: circulating progenitor cells, angiogenesis, and reverse cholesterol transport.

Authors:  Pedro R Moreno; Javier Sanz; Valentin Fuster
Journal:  J Am Coll Cardiol       Date:  2009-06-23       Impact factor: 24.094

3.  Promoting global cardiovascular health: moving forward.

Authors:  Valentin Fuster; Bridget B Kelly; Rajesh Vedanthan
Journal:  Circulation       Date:  2011-04-19       Impact factor: 29.690

4.  Medication adherence: hope for improvement?

Authors:  Robert S Epstein
Journal:  Mayo Clin Proc       Date:  2011-04       Impact factor: 7.616

5.  The BioImage Study: novel approaches to risk assessment in the primary prevention of atherosclerotic cardiovascular disease--study design and objectives.

Authors:  Pieter Muntendam; Carol McCall; Javier Sanz; Erling Falk; Valentin Fuster
Journal:  Am Heart J       Date:  2010-07       Impact factor: 4.749

6.  Optimal medical therapy with or without PCI for stable coronary disease.

Authors:  William E Boden; Robert A O'Rourke; Koon K Teo; Pamela M Hartigan; David J Maron; William J Kostuk; Merril Knudtson; Marcin Dada; Paul Casperson; Crystal L Harris; Bernard R Chaitman; Leslee Shaw; Gilbert Gosselin; Shah Nawaz; Lawrence M Title; Gerald Gau; Alvin S Blaustein; David C Booth; Eric R Bates; John A Spertus; Daniel S Berman; G B John Mancini; William S Weintraub
Journal:  N Engl J Med       Date:  2007-03-26       Impact factor: 91.245

Review 7.  Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time?

Authors:  James H F Rudd; Jagat Narula; H William Strauss; Renu Virmani; Josef Machac; Mike Klimas; Nobuhiro Tahara; Valentin Fuster; Elizabeth A Warburton; Zahi A Fayad; Ahmed A Tawakol
Journal:  J Am Coll Cardiol       Date:  2010-06-08       Impact factor: 24.094

8.  A prospective natural-history study of coronary atherosclerosis.

Authors:  Gregg W Stone; Akiko Maehara; Alexandra J Lansky; Bernard de Bruyne; Ecaterina Cristea; Gary S Mintz; Roxana Mehran; John McPherson; Naim Farhat; Steven P Marso; Helen Parise; Barry Templin; Roseann White; Zhen Zhang; Patrick W Serruys
Journal:  N Engl J Med       Date:  2011-01-20       Impact factor: 91.245

Review 9.  MRI of carotid atherosclerosis: clinical implications and future directions.

Authors:  Hunter R Underhill; Thomas S Hatsukami; Zahi A Fayad; Valentin Fuster; Chun Yuan
Journal:  Nat Rev Cardiol       Date:  2010-01-26       Impact factor: 32.419

10.  Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial.

Authors:  Zahi A Fayad; Venkatesh Mani; Mark Woodward; David Kallend; Markus Abt; Tracy Burgess; Valentin Fuster; Christie M Ballantyne; Evan A Stein; Jean-Claude Tardif; James H F Rudd; Michael E Farkouh; Ahmed Tawakol
Journal:  Lancet       Date:  2011-09-09       Impact factor: 79.321

View more
  6 in total

Review 1.  Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2013-10-21

Review 2.  Conceptual heuristic models of the interrelationships between obesity and the occupational environment.

Authors:  Sudha P Pandalai; Paul A Schulte; Diane B Miller
Journal:  Scand J Work Environ Health       Date:  2013-04-15       Impact factor: 5.024

Review 3.  Top 10 cardiovascular therapies and interventions for the next decade.

Authors:  Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2014-09-30       Impact factor: 32.419

Review 4.  Endpoints in stem cell trials in ischemic heart failure.

Authors:  Marko Banovic; Zlatibor Loncar; Atta Behfar; Marc Vanderheyden; Branko Beleslin; Andreas Zeiher; Marco Metra; Andre Terzic; Jozef Bartunek
Journal:  Stem Cell Res Ther       Date:  2015-08-29       Impact factor: 6.832

5.  Exercise, oxidants, and antioxidants change the shape of the bell-shaped hormesis curve.

Authors:  Zsolt Radak; Kazunari Ishihara; Eva Tekus; Csaba Varga; Aniko Posa; Laszlo Balogh; Istvan Boldogh; Erika Koltai
Journal:  Redox Biol       Date:  2017-03-03       Impact factor: 11.799

Review 6.  Effect of Flaxseed Intervention on Inflammatory Marker C-Reactive Protein: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Guan-Yu Ren; Chun-Yang Chen; Guo-Chong Chen; Wei-Guo Chen; An Pan; Chen-Wei Pan; Yong-Hong Zhang; Li-Qiang Qin; Li-Hua Chen
Journal:  Nutrients       Date:  2016-03-04       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.